Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Pancreatic Neuroendocrine Tumor:Factor of Surgery Influencing Survival

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02624154
Recruitment Status : Unknown
Verified November 2015 by Qinchang Chen, First Affiliated Hospital, Sun Yat-Sen University.
Recruitment status was:  Not yet recruiting
First Posted : December 8, 2015
Last Update Posted : December 8, 2015
Sponsor:
Information provided by (Responsible Party):
Qinchang Chen, First Affiliated Hospital, Sun Yat-Sen University

Tracking Information
First Submitted Date November 30, 2015
First Posted Date December 8, 2015
Last Update Posted Date December 8, 2015
Study Start Date December 2015
Estimated Primary Completion Date June 2016   (Final data collection date for primary outcome measure)
Current Primary Outcome Measures
 (submitted: December 4, 2015)
The survival rate [ Time Frame: 3 years ]
Original Primary Outcome Measures Same as current
Change History No Changes Posted
Current Secondary Outcome Measures Not Provided
Original Secondary Outcome Measures Not Provided
Current Other Pre-specified Outcome Measures Not Provided
Original Other Pre-specified Outcome Measures Not Provided
 
Descriptive Information
Brief Title Pancreatic Neuroendocrine Tumor:Factor of Surgery Influencing Survival
Official Title Pancreatic Neuroendocrine Tumor:Factor of Surgery Influencing Survival
Brief Summary Investigator determined the factor of surgery associated with the survival of pancreatic neuroendocrine tumor.
Detailed Description The variables including clinical characteristics, surgical data and pathological findings are examined by univariate and multivariate analyses.
Study Type Observational
Study Design Observational Model: Case-Only
Time Perspective: Retrospective
Target Follow-Up Duration Not Provided
Biospecimen Not Provided
Sampling Method Probability Sample
Study Population Investigators selected the patient who underwent pancreatectomy during the time from 2010 to 2013 at the First Affiliated Hospital of Sun Yat-sen University.
Condition Pancreatic Neuroendocrine Tumor
Intervention Procedure: pancreatectomy
Remove the pancreatic neuroendocrine tumor by surgery
Study Groups/Cohorts Not Provided
Publications * Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status Unknown status
Estimated Enrollment
 (submitted: December 4, 2015)
2
Original Estimated Enrollment Same as current
Estimated Study Completion Date December 2016
Estimated Primary Completion Date June 2016   (Final data collection date for primary outcome measure)
Eligibility Criteria

Inclusion Criteria:

  • The patients with pancreatic neuroendocrine tumor underwent pancreatectomy

Exclusion Criteria:

  • The patients with pancreatic neuroendocrine tumor did not undergo pancreatectomy
Sex/Gender
Sexes Eligible for Study: All
Ages 10 Years to 80 Years   (Child, Adult, Older Adult)
Accepts Healthy Volunteers No
Contacts Contact information is only displayed when the study is recruiting subjects
Listed Location Countries Not Provided
Removed Location Countries  
 
Administrative Information
NCT Number NCT02624154
Other Study ID Numbers SYSU 211
Has Data Monitoring Committee Yes
U.S. FDA-regulated Product Not Provided
IPD Sharing Statement Not Provided
Responsible Party Qinchang Chen, First Affiliated Hospital, Sun Yat-Sen University
Study Sponsor First Affiliated Hospital, Sun Yat-Sen University
Collaborators Not Provided
Investigators
Study Director: Shaowei Gao, Doctor First Affiliated Hospital, Sun Yat-Sen University
PRS Account First Affiliated Hospital, Sun Yat-Sen University
Verification Date November 2015